North China Pharmaceutical Co Ltd (600812) — Capital Reinvestment Ratio
North China Pharmaceutical Co Ltd (600812) has a Capital Reinvestment Ratio of 0.85x as of September 2025, meaning it reinvests 1% of its operating cash flow (CN¥170.24 Million) in capital expenditures (CN¥144.38 Million). See 600812 equity financing ratio to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
North China Pharmaceutical Co Ltd Capital Reinvestment Ratio (2000–2025)
This chart tracks North China Pharmaceutical Co Ltd's Capital Reinvestment Ratio across 22 annual periods. Check 600812 capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for North China Pharmaceutical Co Ltd (2000–2025)
Year-by-year Capital Reinvestment Ratio for North China Pharmaceutical Co Ltd from 2000 to 2025. For live market cap and broader valuation context, see 600812 market cap.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.46x | CN¥1.18 Billion | CN¥542.01 Million | ▼ -27.8% |
| 2024 | 0.64x | CN¥1.23 Billion | CN¥784.22 Million | ▲ +4.9% |
| 2023 | 0.61x | CN¥1.02 Billion | CN¥623.04 Million | ▲ +11.2% |
| 2022 | 0.55x | CN¥1.00 Billion | CN¥549.58 Million | ▲ +5.0% |
| 2021 | 0.52x | CN¥1.05 Billion | CN¥547.50 Million | ▼ -61.1% |
| 2020 | 1.34x | CN¥752.15 Million | CN¥1.01 Billion | ▲ +51.9% |
| 2019 | 0.88x | CN¥732.97 Million | CN¥645.97 Million | ▲ +34.7% |
| 2018 | 0.65x | CN¥774.33 Million | CN¥506.64 Million | ▼ -53.0% |
| 2017 | 1.39x | CN¥287.25 Million | CN¥399.69 Million | ▼ -53.7% |
| 2015 | 3.00x | CN¥122.50 Million | CN¥367.81 Million | ▲ +5.3% |
| 2014 | 2.85x | CN¥90.56 Million | CN¥258.30 Million | ▼ -42.9% |
| 2011 | 4.99x | CN¥227.60 Million | CN¥1.14 Billion | ▲ +1279.5% |
| 2009 | 0.36x | CN¥1.01 Billion | CN¥366.10 Million | ▲ +184.8% |
| 2008 | 0.13x | CN¥1.09 Billion | CN¥138.00 Million | ▼ -14.1% |
| 2007 | 0.15x | CN¥664.37 Million | CN¥98.27 Million | ▲ +70.8% |
| 2006 | 0.09x | CN¥597.12 Million | CN¥51.72 Million | ▼ -89.5% |
| 2005 | 0.82x | CN¥224.17 Million | CN¥184.67 Million | ▼ -26.6% |
| 2004 | 1.12x | CN¥310.39 Million | CN¥348.50 Million | ▲ +47.2% |
| 2003 | 0.76x | CN¥580.32 Million | CN¥442.77 Million | ▲ +150.8% |
| 2002 | 0.30x | CN¥738.50 Million | CN¥224.68 Million | ▼ -41.7% |
| 2001 | 0.52x | CN¥367.28 Million | CN¥191.79 Million | ▼ -28.5% |
| 2000 | 0.73x | CN¥133.49 Million | CN¥97.52 Million | — |